Literature DB >> 12711060

Determination of hepatitis C virus genotype by Pyrosequencing.

Elahe Elahi1, Nader Pourmand, Ramsey Chaung, Ara Rofoogaran, Judie Boisver, Katayon Samimi-Rad, Ronald W Davis, Mostafa Ronaghi.   

Abstract

A simple sequencing-based assay is described for genotyping of hepatitis C virus (HCV). RT-PCR was employed to amplify a 237-nucleotide-long fragment from the 5' untranslated region (UTR) of the genome using one biotinylated and one normal primer. Subsequent to capture of the PCR products on streptavidin-coated beads, single-stranded DNA separation, and hybridization of sequencing primer, Pyrosequencing was performed. The genotype of 98 samples out of which 77 samples were from American veterans and 21 samples were from Iran was determined. The samples from the American veterans contained six different subtypes, while five subtypes were found in Iranian samples. For rapid population-specific HCV subtyping, a multiplex assay was developed. This study demonstrates the suitability of this technology for low-cost, high throughput and accurate microbial genotyping.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711060     DOI: 10.1016/s0166-0934(03)00068-5

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  13 in total

1.  Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci.

Authors:  Alistair Sinclair; Catherine Arnold; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

Review 2.  Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory.

Authors:  W M Dunne; L F Westblade; B Ford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-08       Impact factor: 3.267

3.  Analysis of read length limiting factors in Pyrosequencing chemistry.

Authors:  Foad Mashayekhi; Mostafa Ronaghi
Journal:  Anal Biochem       Date:  2007-02-13       Impact factor: 3.365

4.  High levels of genetic variation within core Helicoverpa armigera nucleopolyhedrovirus genes.

Authors:  Vicky Lynne Baillie; Gustav Bouwer
Journal:  Virus Genes       Date:  2011-09-10       Impact factor: 2.332

5.  Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans.

Authors:  Joanna S Ellis; Joanne W Smith; Sharleen Braham; Matthew Lock; Katrina Barlow; Maria C Zambon
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

6.  Genotyping and infection rate of GBV-C among Iranian HCV- infected patients.

Authors:  Reza Ghanbari; Mehrdad Ravanshad; Seyed Younes Hosseini; Ramin Yaghobi; Kiana Shahzamani
Journal:  Hepat Mon       Date:  2010-06-01       Impact factor: 0.660

7.  Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study.

Authors:  Ali Kabir; Seyed-Moayed Alavian; Hussein Keyvani
Journal:  Comp Hepatol       Date:  2006-10-02

8.  Evidence to support natural hybridization between Anopheles sinensis and Anopheles kleini (Diptera: Culicidae): possibly a significant mechanism for gene introgression in sympatric populations.

Authors:  Wej Choochote; Gi-Sik Min; Pewpan M Intapan; Chairat Tantrawatpan; Atiporn Saeung; Viraphong Lulitanond
Journal:  Parasit Vectors       Date:  2014-01-20       Impact factor: 3.876

9.  Pyrosequencing trade mark : A one-step method for high resolution HLA typing.

Authors:  Daniel Ramon; Megan Braden; Sharon Adams; Francesco M Marincola; Lu Wang
Journal:  J Transl Med       Date:  2003-11-26       Impact factor: 5.531

10.  Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccines.

Authors:  Svetlana V Shcherbik; Nicholas C Pearce; Marnie L Levine; Alexander I Klimov; Julie M Villanueva; Tatiana L Bousse
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.